VF
ADCT icon

Virtu Financial’s ADC Therapeutics ADCT Stock Holding History

Virtu Financial’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45K Buy
+12,098
New +$47.7K ﹤0.01% 1304
2025
Q3 		– Sell
-59,548
Closed -$160K – 1415
2025
Q2 		$160K Buy
+59,548
New +$125K 0.01% 962
2023
Q3 		– Sell
-18,835
Closed -$40K – 1223
2023
Q2 		$40K Buy
+18,835
New +$42.3K ﹤0.01% 1169

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virtu Financial's ADCT Position: Q1 2026 in Review

Virtu Financial opened a new position in ADC Therapeutics (ADCT) in Q1 2026: 12,098 shares worth $45K. The stake represents ﹤0.01% of the portfolio and ranks #1304 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ADCT as recently as Q2 2025.

Virtu Financial first reported a position in ADCT in Q2 2023 and has held it in 3 quarters since. The position peaked at $160K in Q2 2025. 118 funds tracked by Wall St. Rank hold ADCT as of Q1 2026.

  • Virtu Financial held 12,098 shares of ADC Therapeutics worth $45K as of Q1 2026.
  • ADC Therapeutics was a new Virtu Financial position in Q1 2026.
  • ADC Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1304 holding.
  • Virtu Financial first reported a position in ADC Therapeutics in Q2 2023 and has held it in 3 quarters since.
  • Virtu Financial's ADC Therapeutics position peaked at $160K in Q2 2025.
  • 118 funds tracked by Wall St. Rank held ADC Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.